Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hossein Hashemi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Analytica Chimica Acta|May 25, 2010
Electrodeposited nano-scale islands of ruthenium oxide as a bifunctional electrocatalyst for simultaneous catalytic oxidation of hydrazine and hydroxylamineHamid R Zare, S Hossein Hashemi, Ali Benvidi
Journal of Biomedical Nanotechnology|January 9, 2010
Complement: alive and kicking nanomedicinesAlina J Andersen, S Hossein Hashemi, Thomas L Andresen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 12, 2011
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issuesDavide Brambilla, Benjamin Le Droumaguet, Julien Nicolas, et al.
ACS Nano|June 13, 2012
PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's diseaseDavide Brambilla, Romain Verpillot, Benjamin Le Droumaguet, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Analytica Chimica Acta|May 25, 2010
Electrodeposited nano-scale islands of ruthenium oxide as a bifunctional electrocatalyst for simultaneous catalytic oxidation of hydrazine and hydroxylamineHamid R Zare, S Hossein Hashemi, Ali Benvidi
Journal of Biomedical Nanotechnology|January 9, 2010
Complement: alive and kicking nanomedicinesAlina J Andersen, S Hossein Hashemi, Thomas L Andresen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 12, 2011
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issuesDavide Brambilla, Benjamin Le Droumaguet, Julien Nicolas, et al.
ACS Nano|June 13, 2012
PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's diseaseDavide Brambilla, Romain Verpillot, Benjamin Le Droumaguet, et al.
Pageof 1